Activation of coagulation by a LDL-apheresis device

Blood Coagulation and Fibrinolysis

Volumn 7, Issue 4, 1996, Pages 447-452

  Giansante, C ^a   Bordin, P ^a   Fiotti, N ^a   Calabrese, S ^a   Petrucco, A ^a   Da Col, P G ^a   Fonda, M ^a   Cattin, L ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

coagulation indicators; fibrinogen; LDL apheresis

Indexed keywords

ANTITHROMBIN; FIBRINOGEN; LOW DENSITY LIPOPROTEIN; THROMBIN;

ADULT; AGED; APHERESIS; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HUMAN; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL;

EID: 0029766842     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199606000-00003     Document Type: Article

References (21)

1. Anonymous. Summary of the second Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993; 269: 3015-3023.
2. Yokoyama S, Hayashi R, Satani M, Yamamoto A. Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985; 5: 613-622.
3. Kojima S, Harada-Shiba M, Toyota Y, et al. Changes in coagulation factors by passage through a dextran sulphate cellulose column during low-density lipoprotein apheresis. Int J Artif Organs 1992; 15: 185-190.
4. Bordin P, Petrucco A, Fiotti N, Giacomello R, Gattin L. A fibrin clot stops LDL-apheresis. ASAIO J 1995; 41: 234-235.
5. Prisco D. Markers of increased thrombin generation. Res Clin Lab 1990; 20: 217-225.
6. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 1988; 59: 101-106.
7. Elias A, Bonfils S, Daoud-Elias M, et al. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-dimer levels in patients affected by proximal deep vein thrombosis. Thromb Haemost 1993; 69: 302-305.
8. Boneu B, Bes G, Pelzer H, Siè P, Boccalon H. D-dimers, thrombin antithrombin III complexes and prothrombin fragments 1 + 2: diagnostic value of clinically suspected deep vein thrombosis. Thromb Haemost 1991; 65: 28-32.
9. Lelli N, Garuti R, Pedrazzi P, et al. A new missense mutation (Cys 297 Phe) of low density lipoprotein receptor in Italian patients with familial hypercholesterolemia (FH Trieste). Hum Genet 1994; 93: 538-540.
10. von Clauss A. Gerinnungphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol 1957; 17: 237-246.
11. Giansante C, Fiotti N, Gattin L, Da Col PG, Calabrese S. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationship with other cardiovascular risk factors. Thromb Haemost 1994; 71: 581-586.
12. Hatanaka K, Uchida K, Skai H, Kurata M, Li X, Yamamoto A. The effect of low-density lipoprotein apheresis on plasma thrombomodulating factors. ASAIO J 1992; 38: 102-107.
13. Schuff-Werner P, Schutz E, Eisenhauer T, Armstrong VW. Long-term fibrinogen lowering therapy by regular LDL/ fibrinogen precipitation with the HELP-System. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: A New Cardiovascular Risk Factor. Wien: Blackwell-MZV, 1992: 403-407.
14. Knisel W, Di Nicuolo A, Pfohl M, et al. Different effects of two methods of low-density lipoprotein apheresis on the coagulation and fibrinolytic system. J Intern Med 1993; 234: 479-487.
15. Koenig W, Ditschuneit HH, Hehr R, Staub JP, Grunewald RW, Hombach V. Blood rheology after low density lipoprotein (LDL) apheresis using dextran sulfate cellulose adsorption. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: A New Cardiovascular Risk Factor. Wien: Blackwell-MZV, 1992: 413-417.
16. Palareti G, Maccaferri M, Poggi M, et al. Fibrinogen measurement in various clinical conditions: a comparison of five different methods. In: Ernst E, Koenig W, Lowe GDO, Meade TW, eds. Fibrinogen: A New Cardiovascular Risk Factor. Wien: Blackwell-MZV, 1992: 64-67.
17. Reber G, Stoermann C, de Moerloose P, Ruedin P, Leski M. Hemostatic disturbance induced by two hollow-fiber hemodialysis membranes. Int J Artif Organs 1992; 15: 269-276.
18. Cornelius RM, Brash JL. Identification of proteins absorbed to haemodialyser membranes from heparinized plasma J Biomater Sci Polim Ed 1993; 4: 291-304.
19. Kinugasa E, Akizawa T, Nakashima Y, Wakasa M, Koshikawa S. Nafamostat as anticoagulant for membrane plasmapheresis in high bleeding risk patients. Int J Artif Organs 1992; 15: 595-600.
20. Inagaki O, Nishian Y, Iwaki R, Nakagawa K, Takamisu Y, Fujita Y. Adsorption of nafamostat mesilate by hemodialysis membranes. Artif Organs 1992; 16: 553-558.
21. Akizawa T, Koshikawa S, Ota K, Kazama M, Mimura N, Hirasawa Y. Nafamostat mesilate: a regional anticoagulant for hemodialysis in patients at high risk for bleeding. Nefron 1993; 64: 376-381.